Drug Type Small molecule drug |
Synonyms- |
Mechanism 5-HT1A receptor partial agonists(Serotonin 1a (5-HT1a) receptor partial agonists), 5-HT2A receptor partial agonists(Serotonin 2a (5-HT2a) receptor partial agonists), D2 receptor partial agonists(Dopamine D2 receptor partial agonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H26Cl3N3O3 |
InChIKeyGMTQOJSRMVAFIF-UHFFFAOYSA-N |
CAS Registry1708960-04-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Preclinical | CN | 02 May 2018 |